Dhone, P.G., Behera, D., Gupta, V. and Mubeen, M.F. 2022. To evaluate the safety and efficacy of saroglitazar among pre-diabetes and dyslipidemia. International journal of health sciences. 6, S2 (Jun. 2022), 13816–13823. DOI:https://doi.org/10.53730/ijhs.v6nS2.8835.